Chad Cowan serves as Executive at Century Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Chad Cowan has executed 3 insider transactions totaling $52.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 22, 2025 involved purchasing 58,060 shares valued at $49.4K.
Chad Cowan currently holds 1,045,087 shares of Century Therapeutics, Inc. (IPSC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chad Cowan has been a net buyer of IPSC stock. They have purchased $49.4K and sold $2.7K worth of shares.
Chad Cowan's most recent insider trade was on Dec 22, 2025, when they purchased 58,060 shares at $0.85 per share.
Get notified when new Form 4 filings are submitted
| $0.50 |
| Discretionary |
| Sep 18, 2025 | IPSC | $0 | Award | 762,543 | $N/A | Discretionary |